Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-14-005979
Filing Date
2014-10-15
Accepted
2014-10-15 14:32:52
Documents
11
Period of Report
2014-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 305274
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 6530
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 6556
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 1290
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 1316
  Complete submission text file 0001062993-14-005979.txt   3778268

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE orgs-20140831.xml EX-101.INS 260883
7 XBRL SCHEMA FILE orgs-20140831.xsd EX-101.SCH 108436
8 XBRL CALCULATION FILE orgs-20140831_cal.xml EX-101.CAL 34449
9 XBRL DEFINITION FILE orgs-20140831_def.xml EX-101.DEF 290030
10 XBRL LABEL FILE orgs-20140831_lab.xml EX-101.LAB 732702
11 XBRL PRESENTATION FILE orgs-20140831_pre.xml EX-101.PRE 321381
Mailing Address 21 SPARROW CIRCLE WHITE PLAINS NY 10605
Business Address 21 SPARROW CIRCLE WHITE PLAINS NY 10605 972.4.8242051
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

EIN.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-54329 | Film No.: 141157368
SIC: 2834 Pharmaceutical Preparations